Androgen ablation promotes neuroendocrine cell differentiation in dog and human prostate.
- Published in:
- Prostate, 2002, v. 51, n. 2, p. 117, doi. 10.1002/pros.10066
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2002 AND VI 51 AND IP 2
Results: 8
1
2
Intermediate cells in normal and malignant prostate epithelium express c-MET: Implications for prostate cancer invasion.
- Published in:
- Prostate, 2002, v. 51, n. 2, p. 98, doi. 10.1002/pros.10073
- By:
- Publication type:
- Article
3
Growth inhibition of prostate cancer xenografts by halofuginone.
- Published in:
- Prostate, 2002, v. 51, n. 2, p. 73, doi. 10.1002/pros.10059
- By:
- Publication type:
- Article
4
Inhibitors of apoptosis proteins in prostate cancer cell lines.
- Published in:
- Prostate, 2002, v. 51, n. 2, p. 133, doi. 10.1002/pros.10061
- By:
- Publication type:
- Article
5
Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer.
- Published in:
- Prostate, 2002, v. 51, n. 2, p. 108, doi. 10.1002/pros.10058
- By:
- Publication type:
- Article
6
Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo.
- Published in:
- Prostate, 2002, v. 51, n. 2, p. 141, doi. 10.1002/pros.10068
- By:
- Publication type:
- Article
7
Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients.
- Published in:
- Prostate, 2002, v. 51, n. 2, p. 84, doi. 10.1002/pros.10063
- By:
- Publication type:
- Article
8
Down-regulation of the human kallikrein gene 5 ( KLK5) in prostate cancer tissues.
- Published in:
- Prostate, 2002, v. 51, n. 2, p. 126, doi. 10.1002/pros.10067
- By:
- Publication type:
- Article